Target-Specific Extracellular Vesicles via Localized Mutagenesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current exosome-mediated delivery systems face challenges in achieving high efficiency and target-specificity due to low cellular uptake and stability issues, limiting their therapeutic potential.
Innovation Solution
A method is developed to produce target-specific extracellular vesicles by modifying the extravesicular domain of EV surface proteins through mutagenesis, incorporating target binding sites within specific regions of the protein sequence, and displaying these modifications on the surface of EVs using display systems like yeast or phage display, resulting in enhanced target binding characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If exosomes are used as delivery vehicles, then low immunogenicity and low cytotoxicity are achieved, but low cellular uptake and low target-specificity limit therapeutic efficiency
Solution Approach 1:
The patent applies local quality by modifying only the extravesicular domain of EV surface proteins with target-binding sequences, while keeping the rest of the protein and EV structure unchanged. This localized modification approach enables specific target recognition without altering the inherent low immunogenicity and cytotoxicity properties of the native EVs, thus resolving the contradiction between maintaining reliability and improving adaptability.
Solution Approach 2:
The patent employs parameter changes by systematically varying the target-binding sequences incorporated into the extravesicular domain through mutagenesis. This allows optimization of binding affinity and specificity parameters while preserving the fundamental EV structure and biological properties, thereby enhancing target-specificity without compromising therapeutic reliability.
2Reliability
If EV surface proteins are modified through mutagenesis, then target binding affinity is enhanced, but structural stability may be compromised
Solution Approach 1:
The patent applies local quality by restricting mutagenesis modifications to only the extravesicular domain of surface proteins, specifically targeting regions that do not compromise the transmembrane domain or core structural elements. This localized approach enhances target binding affinity while preserving the overall structural stability and proper folding of the EV surface proteins.
Solution Approach 2:
The patent employs partial action by introducing mutations only in specific regions of the extravesicular domain rather than throughout the entire protein sequence. This selective modification strategy achieves enhanced target binding while minimizing disruptions to the protein's global structure and stability, avoiding the need for excessive or comprehensive mutagenesis.
3Productivity
If target binding sites are incorporated in the extravesicular domain, then cellular uptake is improved, but manufacturing complexity increases
Solution Approach 1:
The patent applies local quality by focusing all manufacturing efforts on modifying only the extravesicular domain through targeted mutagenesis, rather than requiring comprehensive redesign of the entire EV system. This localized approach simplifies the manufacturing process while still achieving improved cellular uptake efficiency through enhanced target binding.
Solution Approach 2:
The patent employs preliminary action by incorporating target-binding sequences into the EV surface protein gene sequence before EV production. This upfront genetic modification ensures that the improved cellular uptake capability is built-in during EV biosynthesis, avoiding the need for complex post-production engineering or surface conjugation steps.
Data Source
AI summary
Provided herein is a method of producing a protein comprising a target-specific extravesicular domain (TED) of an extracellular vesicle (EV) surface protein comprising modifying a polynucleotide comprising a nucleotide sequence encoding the extravesicular domain (ED) of an EV surface protein by a mutagenesis method within at least one modified region within the ED amino acid sequence with a length of 3-20 contiguous amino acids flanked by regions of the wild-type ED sequence at its N-terminus and C-terminus, to incorporate a target binding site within the ED, thereby producing a repertoire of polynucleotides encoding a variety of TEDs, each comprising a different target binding site, and selecting a TED specifically recognizing a predetermined target, and producing the protein comprising the selected TED.